摘要
Introduction: The present study aimed to evaluate the influence of biological characteristics of hepatocellular carcinoma (HCC) on the Liver Imaging Reporting and Data System (LI-RADS) v2017 category of contrast-enhanced ultrasound (CEUS) in patients with high risk and compare the outcomes among different categories after radical resection. Methods: Between June 2017 and December 2020, standardized CEUS data of liver nodules were prospectively collected from multiple centers across China. We conducted a retrospective analysis of the prospectively collected data on HCCs measuring no more than 5 cm, as diagnosed by pathology. LI-RADS categories were assigned after thorough evaluation of CEUS features. Then, CEUS LI-RADS categories and major features were compared in different differentiation, Ki-67, and microvascular invasion (MVI) statuses. Differences in recurrence-free survival (RFS) among different LI-RADS categories were further analyzed. Results: A total of 293 HCC nodules in 293 patients were included. This study revealed significant differences in the CEUS LI-RADS category of HCCs among differentiation (p < 0.001) and levels of Ki-67 (p = 0.01) and that poor differentiation (32.7% in LR-M, 12% in LR-5, and 6.2% in LR-4) (p < 0.001) and high level of Ki-67 (median value 30%) were more frequently classified into the LR-M category, whereas well differentiation (37.5% in LR-4, 15.1% in LR-5, and 11.5% in LR-M) and low levels of Ki-67 (median value 11%) were more frequently classified into the LR-4 category. No significant differences were found between MVI and CEUS LI-RADS categories (p > 0.05). With a median follow-up of 23 months, HCCs assigned to different CEUS LI-RADS classes showed no significant differences in RFS after resection. Conclusions: Biological characteristics of HCC, including differentiation and level of Ki-67 expression, could influence major features of CEUS and impact the CEUS LI-RADS category. HCCs in different CEUS LI-RADS categories showed no significant differences in RFS after resection.
学科与关键词
- Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver AgreementZhou, Hang; Zhang, Chao; Du, Linyao; Jiang, Jiapeng; Zhao, Qing; Sun, Jiawei; Li, Qunying; Wan, Ming; Wang, Xiaolei; Hou, Xiujuan; Wen, Qing; Liu, Yajing; Zhou, Xianli; Huang, Pintong*Ultraschall in der Medizin, 2022, 43(01): 64-71.被引 18
- On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter StudyYang, Qi; Zheng, Rongqin; Zhou, Jianhua; Tang, Lina; Zhang, Ruifang; Jiang, Tianan; Jing, Xiang; Liao, Jintang; Cheng, Wen; Zhao, Cheng; Liu, Cun; Dietrich, Chirstoph F.; Cui, Xinwu; Cai, Wenjia; Wu, Jiapeng; Yu, Fei; Cheng, Zhigang; Liu, Fangyi; Han, Zhiyu; Yu, Xiaoling; Yu, Jie*; Liang, Ping*Journal of Ultrasound in Medicine, 2023, 42(12): 2825-2838.
- Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infectionShao, Shuo; Liang, Yingying; Kuang, Sichi; Chen, Jingbiao; Shan, Qungang; Yang, Hao; Zhang, Yao; Wang, Bin; Fowler, Kathryn J.; Wang, Jin*; Sirlin, Claude B.Bosnian Journal of Basic Medical Sciences, 2020, 20(3): 401-410.被引 14
